Exane Derivatives’s Lakeland Bancorp Inc LBAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3.46K Sell
237
-989
-81% -$15.2K ﹤0.01% 404
2022
Q1
$20.5K Buy
1,226
+750
+158% +$13.9K 0.01% 662
2021
Q4
$9.04K Sell
476
-3,734
-89% -$68.6K ﹤0.01% 596
2021
Q3
$74.2K Sell
4,210
-1,212
-22% -$20.1K 0.02% 577
2021
Q2
$89.7K Buy
5,422
+1,417
+35% +$25.7K 0.02% 555
2021
Q1
$69.8K Buy
+4,005
New +$62K 0.02% 478

Other funds holding LBAI

Exane Derivatives's LBAI Position: Q2 2022 in Review

Exane Derivatives reduced its Lakeland Bancorp Inc (LBAI) stake by 81% in Q2 2022, selling an estimated $15.2K and leaving 237 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #404.

Exane Derivatives first reported a position in LBAI in Q1 2021 and has held it in 6 quarters since. The position peaked at $89.7K in Q2 2021. 183 funds tracked by Wall St. Rank hold LBAI as of Q2 2022.

  • Exane Derivatives held 237 shares of Lakeland Bancorp Inc worth $3.46K as of Q2 2022.
  • Exane Derivatives sold 989 Lakeland Bancorp Inc shares in Q2 2022, an estimated $15.2K.
  • Lakeland Bancorp Inc made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #404 holding.
  • Exane Derivatives first reported a position in Lakeland Bancorp Inc in Q1 2021 and has held it in 6 quarters since.
  • Exane Derivatives's Lakeland Bancorp Inc position peaked at $89.7K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held Lakeland Bancorp Inc as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.